Detail of "6591-63-5"

Reference

Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders

Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders. Yakatan, Gerald; Berg, James; Pope, Laura E.; Smith, Richard A. ( Avanir Pharmaceuticals, USA). PCT Int. Appl. WO 2004006930 A1 22 Jan 2004, 105 pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, CZ, DE, DE, DK, DK, DM, DZ, EC, EE, EE, ES, FI, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW, AM; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (English). (World Intellectual Property Organization). CODEN: PIXXD2.Several substances with their cas registry numbers 6591-63-5 and 125-69-9 may be metioned in this study. CLASS: ICM: A61K031-485. ICS: A61K031-49; A61P021-04; A61P025-16; A61P025-28. APPLICATION: WO 2003-US22303 17 Jul 2003. PRIORITY: US 2002-PV396661 17 Jul 2002. DOCUMENT TYPE: Patent CA Section: 1 (Pharmacology) Section cross-reference(s): 63 Pharmaceutical compns. and methods for treating neurol. disorders by administering same are provided. The compns. comprise dextromethorphan in combination with quinidine. .